Top 34 Blade Therapeutics investors
The most complete profiles first. Showing 34 of 34.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Louis BernemanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Manny StockmanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Robert AdelsonVerified
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more
Verified email available
Aaron TanVerified
Venture Capital · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Verified email available
Anurag AgarwalVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Matt CohenVerified
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Paul KellyVerified
Venture Capital, Private Equity Firm · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
James Flynn
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more
Contact details available
Marc Singer
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
William Harrington
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more
Contact details available
Anne
Venture Capital, Private Equity Firm · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Contact details available
Avi Kometz
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Gabriel Douville
Venture Capital · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Contact details available
Kate Madden
Venture Capital, Private Equity Firm · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Contact details available
Kirsten Leute
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Michelle Deaker
Venture Capital, Private Equity Firm · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Contact details available
Nick Gainsley
Venture Capital, Private Equity Firm · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Contact details available
Sarah Meibusch
Venture Capital, Private Equity Firm · Australia
Health CareAutonomous VehiclesE-commerceWomen FoundedPortfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Cameron WheelerVerified
Venture Capital, Investment Partner, Investor · United States
Series BHealth CareInformation Technology (IT)BiotechnologyConsumer HealthPortfolio: Ribon Therapeutics, Neomorph, Blade Therapeutics, Pairwise Plants LLC
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Blade Therapeutics investors are on Angel Roster?
Angel Roster lists 34 Blade Therapeutics investors. 17 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (30), Private Equity Firms (19) and Investment Partner Investors (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Blade Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (5), Series A (5) and Seed (2).
Where are Blade Therapeutics investors based?
Most are based in the United States (26) and Australia (8).
Which companies have Blade Therapeutics investors backed?
The most-backed portfolio companies among them are Rhythm Metabolic (17), Proteon Therapeutics (17), Oncorus (17), Frontier Medicines (17) and TriVascular (17).
How do I contact Blade Therapeutics investors?
Create a free Angel Roster account to search and filter all 34, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.